Michigan Senate Candidate El-Sayed Challenges RFK Jr. and FDA Peptide Policy

Democratic Senate candidate Abdul El-Sayed is publicly countering Robert F. Kennedy Jr.'s claims while also addressing the FDA's new 'enforcement discretion' policy on peptides. El-Sayed, a physician and former Detroit health director, is using his medical background to challenge what he sees as misleading health narratives from RFK Jr. and to question the regulatory approach to peptide therapies. The FDA's recent policy shift allows certain peptide products to remain on the market without immediate enforcement, a move that has raised concerns among some health advocates about safety and oversight. El-Sayed's response highlights the growing tension between public health expertise and alternative health movements in Michigan's competitive Senate race. His stance could resonate with voters concerned about medical misinformation and drug regulation, positioning him as a science-aligned candidate. As the campaign unfolds, his willingness to directly confront high-profile figures like RFK Jr. may define his appeal to health-conscious voters.